Phama Company Shares Rise Ahead of FDA Review
2021年11月2日 - 12:09AM
AllPennyStocks.com
After a surprising rejection in August, two pharma companies are
working toward approval ahead of their Type A meeting with the FDA
for a drug with significant potential
Medexus...
To read the full story on AllPennyStocks.com, click
here.
Medexus Pharmaceuticals (TSX:MDP)
過去 株価チャート
から 5 2024 まで 6 2024
Medexus Pharmaceuticals (TSX:MDP)
過去 株価チャート
から 6 2023 まで 6 2024
